Skip to main content
. 2019 Jun;67(6):884–888. doi: 10.4103/ijo.IJO_708_18

Table 2.

Number of eyes vis-a-vis secondary outcome: Recurrence of ROP following Intravitreal Aflibercept

Type of ROP Total number of eyes Number of Eyes that achieved secondary endpoint: No recurrence of ROP after first injection Number of Eyes that did not achieve secondary endpoint: Recurrence of ROP with second intervention
High risk Prethreshold ROP 14 7 (50%) 7 (50%)
Threshold ROP 8 0 8 (100%)
AP-ROP 24 8 (33%) 16 (66%)